Evidence map›Paper›PMID 34041379›Full record

ArticleHeliyon2021

Andrea Carolina Entrocassi, Alejandra Vanina Catalano, Adriana Graciela Ouviña, Erica Georgina Wilson, Paula Gladys López, Marcelo Rodríguez Fermepin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. A review ofJournal of food science and technology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrea Carolina EntrocassiUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Microbiología Clínica, Ciudad Autónoma de Buenos Aires, Argentina.
Alejandra Vanina CatalanoUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia, Ciudad Autónoma de Buenos Aires, Argentina.
Adriana Graciela OuviñaUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia, Ciudad Autónoma de Buenos Aires, Argentina.
Erica Georgina WilsonUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia, Ciudad Autónoma de Buenos Aires, Argentina.
Paula Gladys LópezUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Farmacognosia, Ciudad Autónoma de Buenos Aires, Argentina.
Marcelo Rodríguez FermepinUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Microbiología Clínica, Ciudad Autónoma de Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydial infections in humans are widely distributed and are responsible for a variety of acute and chronic diseases. Both

Indexed as

Antichlamydial activityArgentinian medicinal plantChlamydia pneumoniaeChlamydia trachomatisHydrocotyle bonariensis

Identifiers

PMID34041379
PMCPMC8141889
OpenAlexW3161656684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.